• Body Vision Medical closed a new private funding round led by Business Asia Consultants, Sprim Global Investments.
• Company develops AI-powered intraoperative imaging used to support diagnosis, biopsy navigation, localized treatment in early-stage lung disease.
• Proceeds earmarked for global expansion to meet rising demand tied to national lung cancer screening programs.
• Commercial footprint includes access to 46 countries via more than 20 distributors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SPRIM Ventures Pte Ltd published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein.